companydata.dkcompanydata.dk

ORIFARM GROUP A/S: Financial statements 2019

CVR: 27347282

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

ORIFARM GROUP A/S (CVR 27347282) has filed annual accounts for 2019. In 2019, the company reported revenue of EUR 13,878,000 and a net result of EUR 34,737,000 compared with EUR 26,454,000 the year before. That is an increase of 38.6% compared with the year before. The profit margin was 250.3%. Equity in the 2019 report amounted to EUR 167,930,000. The solvency ratio was 61.7%. The company had 1,111 employees in the financial year.

Revenue
EUR 13,878,000
Gross Profit
EUR 13,891,000
Profit/Loss
EUR 34,737,000
Equity
EUR 167,930,000
Total Assets
EUR 272,117,000
Employees
1,111

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201913.9M EUR13.9M EUR34.7M EUR167.9M EUR1111
201810M EUR10.1M EUR26.5M EUR136M EUR1036
20178.6M EUR8.8M EUR21.9M EUR117M EUR797
20168.8M EUR8.8M EUR10.2M EUR98.5M EUR960
20159.8M EUR9.8M EUR9.1M EUR90.3M EUR-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Karsten Dybmose Truelsen joins the board of ORIFARM GROUP A/SAug 26, 2019

As of August 26, 2019, Karsten Dybmose Truelsen has joined the board of directors of ORIFARM GROUP A/S.

Bettina Britt Juel Hansen joins the board of ORIFARM GROUP A/SAug 26, 2019

As of August 26, 2019, Bettina Britt Juel Hansen has joined the board of directors of ORIFARM GROUP A/S.

Dan Kyster Hartwig leaves the board of ORIFARM GROUP A/SAug 26, 2019

As of August 26, 2019, Dan Kyster Hartwig has left the board of directors of ORIFARM GROUP A/S.

Bettina Britt Juel Hansen leaves the board of ORIFARM GROUP A/SAug 25, 2019

As of August 25, 2019, Bettina Britt Juel Hansen has left the board of directors of ORIFARM GROUP A/S.

Karen Lykke Sørensen leaves the board of ORIFARM GROUP A/SAug 16, 2019

As of August 16, 2019, Karen Lykke Sørensen has left the board of directors of ORIFARM GROUP A/S.

ORIFARM GROUP A/S: The 2018 annual report is outMay 31, 2019

ORIFARM GROUP A/S has published its annual report for 2018. Revenue came to DKK 10,016,000, and the net result was DKK 26,454,000.

About ORIFARM GROUP A/S

ORIFARM GROUP A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The company was previously named CAREFARM A/S. The management consists of Mads Fink Eriksen and Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Ole Michael Friis, Adeel Ahmad and Bettina Britt Juel Hansen. The company is owned by Orifarm Holding A/S. The company has 211 employees (2026). In 2025, the company reported a gross profit of EUR 1,478,000 and a net result of EUR 51,761,000 compared with EUR 3,260,000 the year before. Equity in the 2025 report amounted to EUR 413,677,000.

Source: annual report 2025, Danish Business Authority